Saint Luke's Newsroom

Oct. 17, 2022
FOX4: Two Local Women Become Best Friends During their Journey with Breast Cancer
Two strangers facing the biggest battles of their lives at Saint Luke's Cancer Institute come out on the other side stronger and as best friends.
Oct. 6, 2022
KMBC: New AI Technology Helps Kansas City Area Doctors Detect Breast Cancer
A tiny tumor can be hard to see with the naked eye, but new technology is helping doctors detect breast cancer earlier than ever before.
Oct. 6, 2022
KMBC: Breast Cancer Survivor Urges Women to get Screened
Dr. Ruby Meierotto, Breast Radiologist at Saint Luke's Cancer Institute, talks about the importance of prevention, and Meghan shares her message for other women. 
Oct. 5, 2022
KCTV: Importance of Early Detection for Breast Cancer
1 in 8 women are diagnosed with breast cancer. Watch this to learn more about prevention and recommendations for women who have no symptoms of the disease.
Oct. 5, 2022
The Harbinger: Can't Unwind
The Harbinger talked to a polysomnographic specialist with Saint Luke's Sleep Disorders Program about the negative effects of sleep deprivation in high schoolers.
Oct. 4, 2022
Iola Register: Hospital Upgrades Medical Records System
Allen County Regional Hospital has upgraded its electronic medical record (EMR) system to the Epic platform.
Medscape logo
Oct. 3, 2022
Medscape: Improve Diagnosis of Type of Heart Failure Common in Diabetes
Medscape talked to Dr. Mikhail Kosiborod about how clinicians can be more diligent in evaluating people at high risk for developing heart failure with reduced ejection fraction.
Sep. 29, 2022
USA Today: When Does Your heart Rate Become a Concern? Here's When Your Pulse is Too High.
Dr. Tracy Stevens, cardiologist at Saint Luke's Mid America Heart Institute, explains why heart rate is just a piece of the whole picture.
Sep. 27, 2022
Healio: DELIVER: Dapagliflozin Cuts Risk for Worsening HF in Adults With, Without Type 2 Diabetes
Dapagliflozin reduces risk for worsening heart failure and cardiovascular death in adults with heart failure with mildly reduced or preserved ejection fraction, regardless of baseline HbA1c.